Rhodomycin A

Rhodomycin A can suppress lung cancer cell progression via modulating Src-related pathways.?Rhodomycin A significantly suppressed cancer cell proliferation, migration, invasion, and clonogenicity in vitro and tumour growth in vivo[1].

Product Specifications

CAS Number

[23666-50-4]

UNSPSC

12352005

Target

Src

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Smiles

CN(C)[C@H]([C@@H]([C@@H](O1)C)O)C[C@@H]1O[C@@H](C[C@]2(O)CC)C(C(O)=C3C(C(C4=CC=CC(O)=C4C3=O)=O)=C5O)=C5[C@H]2O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O)N(C)C

Molecular Formula

C36H48N2O12

Molecular Weight

700.77

References & Citations

[1]Yi-Hua Lai, et al. Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways. Oncotarget. 2015 Sep 22;6 (28) :26252-65.